Abstract

The development of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) has been a critical in vitro advance in the study of patient-specific physiology, pathophysiology, and pharmacology. We designed a new deep learning multitask network approach intended to address the low throughput, high variability, and immature phenotype of the iPSC-CM platform. The rationale for combining translation and classification tasks is because the most likely application of the deep learning technology we describe here is to translate iPSC-CMs following application of a perturbation. The deep learning network was trained using simulated action potential (AP) data and applied to classify cells into the drug-free and drugged categories and to predict the impact of electrophysiological perturbation across the continuum of aging from the immature iPSC-CMs to the adult ventricular myocytes. The phase of the AP extremely sensitive to perturbation due to a steep rise of the membrane resistance was found to contain the key information required for successful network multitasking. We also demonstrated successful translation of both experimental and simulated iPSC-CM AP data validating our network by prediction of experimental drug-induced effects on adult cardiomyocyte APs by the latter.

Highlights

  • The development of novel technologies has resulted in new ways to study cardiac function and rhythm disorders (Shaheen et al, 2018)

  • We show that developments in induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) experimental technology and cardiac electrophysiological modeling and simulation of iPSC-CMs can be leveraged for the application of Artificial neural networks (ANNs) as a universal approximator (Goodfellow et al, 2016) to find the most accurate mapping function that is capable of learning nonlinear relationships to predict disease phenotype and drug response in cardiac myocytes from immaturity to maturation

  • We developed a data-driven deep learning approach to address the well-known shortcomings in the iPSC-CM platform

Read more

Summary

Introduction

The development of novel technologies has resulted in new ways to study cardiac function and rhythm disorders (Shaheen et al, 2018). One such technology is the induced pluripotent stem cellderived cardiomyocyte (iPSC-CMs) in vitro model system (Leyton-Mange et al, 2014). While utilization of in vitro iPSC-CMs allows for testing of responses to drugs and understanding physiological mechanisms (Tveito et al, 2018; Tveito et al, 2020; Sube and Ertel, 2017; Navarrete et al, 2013), there is still a major inherent limitation of the approach: the complex differentiation process to create iPSC-CMs results in a model of cardiac electrical behavior that resembles fetal cardiomyocytes.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call